SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-206945
Filing Date
2021-07-02
Accepted
2021-07-02 06:07:30
Documents
3
Period of Report
2021-07-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d64933d8k.htm 8-K 17190
2 EX-99.1 d64933dex991.htm EX-99.1 10614
3 GRAPHIC g64933cerevel.jpg GRAPHIC 4923
  Complete submission text file 0001193125-21-206945.txt   35950
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39311 | Film No.: 211067919
SIC: 2834 Pharmaceutical Preparations